![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
MB Rogers, V Rosen, JM Wozney and LJ Gudas
Pharmacology Department, Cornell University Medical College, New York, New York 10021.
Bone morphogenetic proteins-2 and -4 (BMPs-2 and -4) are transforming growth factor beta-related proteins that can induce bone formation in vivo. We observed that the level of endogenous BMP-2 mRNA increased an average of 11-fold on differentiation of F9 embryonal carcinoma cells into parietal endoderm after treatment with retinoic acid (RA) and cAMP, whereas the message for the closely related BMP-4 decreased 12- fold after this treatment. Therefore, the effects of exogenous recombinant BMP-2 protein on the RA-induced differentiation of F9 embryonal carcinoma cells were investigated. BMP-2 addition altered the growth and morphology of RA-treated but not untreated cells. Moreover, the abundance of several messages was affected by exogenous BMP-2 treatment. Notably, the BMP-2 and -4 messages themselves were reduced by the addition of exogenous BMP-2. The observations suggest that RA, which is known to affect bone morphogenesis, may regulate the osteoinductive proteins, BMP-2 and -4. Furthermore, BMP-2 and -4 may be involved in preimplantation embryogenesis.
This article has been cited by other articles:
|
|
 |
|
  D. T. Fritz, S. Jiang, J. Xu, and M. B. Rogers A Polymorphism in a Conserved Posttranscriptional Regulatory Motif Alters Bone Morphogenetic Protein 2 (BMP2) RNA:Protein Interactions Mol. Endocrinol., July 1, 2006; 20(7): 1574 - 1586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Giacomini, M. Paez-Pereda, M. Theodoropoulou, M. Labeur, D. Refojo, J. Gerez, A. Chervin, S. Berner, M. Losa, M. Buchfelder, et al. Bone Morphogenetic Protein-4 Inhibits Corticotroph Tumor Cells: Involvement in the Retinoic Acid Inhibitory Action Endocrinology, January 1, 2006; 147(1): 247 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ferrari, U. Pfeffer, R. Dell'Eva, C. Ambrosini, D. M. Noonan, and A. Albini The Transforming Growth Factor-{beta} Family Members Bone Morphogenetic Protein-2 and Macrophage Inhibitory Cytokine-1 as Mediators of the Antiangiogenic Activity of N-(4-Hydroxyphenyl)Retinamide Clin. Cancer Res., June 15, 2005; 11(12): 4610 - 4619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. K. Zagranichnaya, X. Wu, A. M. Danos, and M. L. Villereal Gene expression profiles in HEK-293 cells with low or high store-operated calcium entry: can regulatory as well as regulated genes be identified? Physiol Genomics, March 21, 2005; 21(1): 14 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Fritz, D. Liu, J. Xu, S. Jiang, and M. B. Rogers Conservation of Bmp2 Post-transcriptional Regulatory Mechanisms J. Biol. Chem., November 19, 2004; 279(47): 48950 - 48958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Abrams, J. Xu, C. Nativelle-Serpentini, S. Dabirshahsahebi, and M. B. Rogers An Evolutionary and Molecular Analysis of Bmp2 Expression J. Biol. Chem., April 16, 2004; 279(16): 15916 - 15928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Qin, J. M. Haberbusch, Z. Zhang, K. J. Soprano, and D. R. Soprano Pre-B Cell Leukemia Transcription Factor (PBX) Proteins Are Important Mediators for Retinoic Acid-dependent Endodermal and Neuronal Differentiation of Mouse Embryonal Carcinoma P19 Cells J. Biol. Chem., April 16, 2004; 279(16): 16263 - 16271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Adams, K. M. Pallante, Z. Niu, A. J. Cohen, J. Lu, and P. S. LeBoy Stimulation of Type-X Collagen Gene Transcription by Retinoids Occurs in Part Through the BMP Signaling Pathway J. Bone Joint Surg. Am., August 1, 2003; 85(90003): 29 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Glozak, Y. Li, R. Reuille, K. H. Kim, M.-N. Vo, and M. B. Rogers Trapping and Characterization of Novel Retinoid Response Elements Mol. Endocrinol., January 1, 2003; 17(1): 27 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ghatpande, A. Ghatpande, J. Sher, M. H. Zile, and T. Evans Retinoid signaling regulates primitive (yolk sac) hematopoiesis Blood, April 1, 2002; 99(7): 2379 - 2386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Heller, Y. Li, K. L. Abrams, and M. B. Rogers Transcriptional Regulation of the Bmp2 Gene. RETINOIC ACID INDUCTION IN F9 EMBRYONAL CARCINOMA CELLS AND SACCHAROMYCES CEREVISIAE J. Biol. Chem., January 15, 1999; 274(3): 1394 - 1400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Russell, S. Bennett, and P. Stricker Growth factor involvement in progression of prostate cancer Clin. Chem., April 1, 1998; 44(4): 705 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Raval, H.H.T. Hsu, D.J. Schneider, M.P. Sarras JR, K. Masuhara, L.F. Bonewald, and H.C. Anderson Expression of Bone Morphogenetic Proteins by Osteoinductive and Non-osteoinductive Human Osteosarcoma Cells Journal of Dental Research, July 1, 1996; 75(7): 1518 - 1523. [Abstract] [PDF]
|
|
|
|
 |
|
 C Mendelsohn, D Lohnes, D Decimo, T Lufkin, M LeMeur, P Chambon, and M Mark Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants Development, January 10, 1994; 120(10): 2749 - 2771. [Abstract] [PDF]
|
|
|
|
|
|
G Vidricaire, K Jardine, and M. McBurney Expression of the Brachyury gene during mesoderm development in differentiating embryonal carcinoma cell cultures Development, January 1, 1994; 120(1): 115 - 122. [Abstract] [PDF]
|
|
